ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Martela Oyj

Martela Oyj (0F6D)

3.135
0.00
( 0.00% )
Updated: 19:00:00

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
3.135
Bid
3.06
Ask
3.21
Volume
0.00
0.00 Day's Range 0.00
3.135 52 Week Range 3.135
Market Cap
Previous Close
3.135
Open
-
Last Trade
(O)
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
0.00
Shares Outstanding
3,967,000
Dividend Yield
-
PE Ratio
-3.53
Earnings Per Share (EPS)
-0.89
Revenue
94.54M
Net Profit
-3.51M

About Martela Oyj

Sector
Public Bldg & Rel Furniture
Industry
Office Furniture Mfg
Website
Headquarters
Helsinki, Fin
Founded
1990
Martela Oyj is listed in the Public Bldg & Rel Furniture sector of the London Stock Exchange with ticker 0F6D. The last closing price for Martela Oyj was 3.14 €. Over the last year, Martela Oyj shares have traded in a share price range of 3.135 € to 3.135 €.

Martela Oyj currently has 3,967,000 shares outstanding. The market capitalization of Martela Oyj is 12.44 € million. Martela Oyj has a price to earnings ratio (PE ratio) of -3.53.

0F6D Latest News

Martela plans to streamline its operations

Martela plans to streamline its operations Martela Corporation, inside information, 3.1.2025, at 10:25 The continued challenging market situation in recent years has affected Martela's operating...

Martela weakens its guidance for revenue and profit for 2024

Martela weakens its guidance for revenue and profit for 2024 Martela Corporation, inside information, 11.12.2024, at 10:45 Order intake has continued to grow strongly during the current quarter...

MARTELA CORPORATION’S FINANCIAL INFORMATION IN 2025

MARTELA CORPORATION’S FINANCIAL INFORMATION IN 2025 Martela Corporation, Financial calendar, 5.12.2024, at 10:00 a.m.  Martela Corporation’s financial information in 2025 will be published as...

MARTELA CORPORATION’S INTERIM REPORT 1 JANUARY – 30 SEPTEMBER 2024

MARTELA CORPORATION’S INTERIM REPORT 1 JANUARY – 30 SEPTEMBER 2024 Martela Corporation, Interim report, 8.11.2024, at 08:00 a.m. The revenue and operating result for January-September 2024...

MARTELA CORPORATION: DISCLOSURE UNDER CHAPTER 9, SECTION 10 OF THE SECURITIES MARKET ACT

MARTELA CORPORATION: DISCLOSURE UNDER CHAPTER 9, SECTION 10 OF THE SECURITIES MARKET ACT Martela Corporation, Stock Exchange Release, 11.10.2024, at 13:15 Martela Corporation has received an...

Martela weakens its guidance for revenue and profit for 2024

Martela weakens its guidance for revenue and profit for 2024 Martela Corporation, inside information, 27.9.2024, at 11:00 The growth in order intake that started towards the end of the second...

MARTELA CORPORATION: DISCLOSURE UNDER CHAPTER 9, SECTION 10 OF THE SECURITIES MARKET ACT

MARTELA CORPORATION: DISCLOSURE UNDER CHAPTER 9, SECTION 10 OF THE SECURITIES MARKET ACT Martela Corporation, Stock Exchange Release, 18.9.2024, at 16:30 Martela Corporation has received an...

MARTELA CORPORATION: DISCLOSURE UNDER CHAPTER 9, SECTION 10 OF THE SECURITIES MARKET ACT

MARTELA CORPORATION: DISCLOSURE UNDER CHAPTER 9, SECTION 10 OF THE SECURITIES MARKET ACT Martela Corporation, Stock Exchange Release, 18.9.2024, at 16:30 Martela Corporation has received an...

MARTELA CORPORATION’S HALF YEAR REPORT 1 JANUARY – 30 JUNE

MARTELA CORPORATION’S HALF YEAR REPORT 1 JANUARY – 30 JUNE Martela Corporation, Half year report, 16.8.2024, at 08:00 a.m. January-June 2024 revenue and operating loss decreased compared to the...

REGISTRATION OF MARTELA OYJ SHARES OF THE DIRECTED SHARE ISSUE AND APPLICATION FOR PUBLIC LISTING

REGISTRATION OF MARTELA OYJ SHARES OF THE DIRECTED SHARE ISSUE AND APPLICATION FOR PUBLIC LISTING Martela Corporation, Stock Exchange Release, 4.6.2024, at 12:00 Martela Corporation announced on...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1003.1353.1353.13500DE
4003.1353.1353.13500DE
12003.1353.1353.13500DE
26003.1353.1353.13500DE
52003.1353.1353.13500DE
156003.1353.1353.13500DE
260003.1353.1353.13500DE

0F6D - Frequently Asked Questions (FAQ)

What is the current Martela Oyj share price?
The current share price of Martela Oyj is 3.135 €
How many Martela Oyj shares are in issue?
Martela Oyj has 3,967,000 shares in issue
What is the market cap of Martela Oyj?
The market capitalisation of Martela Oyj is EUR 12.44M
What is the 1 year trading range for Martela Oyj share price?
Martela Oyj has traded in the range of 3.135 € to 3.135 € during the past year
What is the PE ratio of Martela Oyj?
The price to earnings ratio of Martela Oyj is -3.53
What is the cash to sales ratio of Martela Oyj?
The cash to sales ratio of Martela Oyj is 0.13
What is the reporting currency for Martela Oyj?
Martela Oyj reports financial results in EUR
What is the latest annual turnover for Martela Oyj?
The latest annual turnover of Martela Oyj is EUR 94.54M
What is the latest annual profit for Martela Oyj?
The latest annual profit of Martela Oyj is EUR -3.51M
What is the registered address of Martela Oyj?
The registered address for Martela Oyj is TAKKATIE 1, P.O.BOX 44, HELSINKI, FI-00371
What is the Martela Oyj website address?
The website address for Martela Oyj is www.martela.fi
Which industry sector does Martela Oyj operate in?
Martela Oyj operates in the OFFICE FURNITURE MFG sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TM1Technology Minerals Plc
0.15p
(25.00%)
11.71M
OMIOrosur Mining Inc
8.25p
(17.02%)
271.26k
SOSSosandar Plc
7.25p
(16.00%)
1.29M
MASTMast Energy Developments Plc
0.20p
(14.29%)
13.72M
ZIOCZanaga Iron Ore Company Limited
8.98p
(13.81%)
23.49k
EYEEagle Eye Solutions Group Plc
380.00p
(-19.32%)
19.66k
THSTharisa Plc
55.00p
(-15.38%)
83.85k
ZENZenith Energy Ltd.
5.50p
(-10.57%)
323.6k
EPPEnergypathways Plc
8.50p
(-9.57%)
571.5k
4GBL4global Plc
45.50p
(-9.00%)
95
TRPTower Resources Plc
0.0405p
(2.53%)
181.62M
CPXCap-xx Limited
0.15p
(-7.69%)
43.1M
NFXNuformix Plc
0.06p
(0.00%)
32.21M
MSMNMosman Oil And Gas Limited
0.0325p
(-1.52%)
29.35M
VRSVersarien Plc
0.033p
(-8.33%)
27.14M

Discussion

View Full Feed
Hi_Lo Hi_Lo 6 minutes ago
Lol!! I want profits!! What you want helps me in no way!!
Exactly. Because the truth with documentation that BCAP is a scam and Jake P. Noch is a serial scammer prevents pumping liars like you from making profits. And that's part of my goal - and to help people know the facts about this scam
BCAP
DiamondHealer95 DiamondHealer95 9 minutes ago
What do you expect and how can you back your thoughts? Thanks
KBLB
DiamondHealer95 DiamondHealer95 15 minutes ago
I mean Kim said once they hit 1.5 metric tons they're open for business and they're about halfway there so..... You're a genius! Congrats on the business. I also run one with 100% positive feedback over 22 years so I get the perspective🤪

Also, in my Arby's voice "I have the
KBLB
DiamondHealer95 DiamondHealer95 19 minutes ago
We've invested similarly
KBLB
sunspotter sunspotter 30 minutes ago
Glenn Miller’s still missing, and Emil Malak and Rich Inza are still crooks.
VPLM
Flobewan Flobewan 41 minutes ago
Marc loved your ides
tinojax tinojax 42 minutes ago
I usually enjoy a beer with my pizza...........I would like to know what's in the Kool Aid........
PLUG
mrfence mrfence 44 minutes ago
Here we are on the cusp of the Monsta $FMCC~ $FNMA~ Gains we've all been waiting for doin da Heebie Jeebie Dance, 😃😄😁😆😅😂!
[yt]MUB3ZR4F8vw?si=Z3oB5zc_RHMtCGEY[/yt]
FMCC FNMA
IVRT IVRT 1 hour ago
In my opinion, there will likely be significant pressure on the share price leading up to the conference call. A sell-off could occur the day before, with the stock potentially bottoming out by the end of the investor call. I could be wrong, but I've seen similar patterns many times over the past 25
BMXI
DewDiligence DewDiligence 1 hour ago
GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

ENTA
DewDiligence DewDiligence 1 hour ago
GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

Guido2 Guido2 1 hour ago
This is DUE DILIGENCE! Thank you Free Fannie.

https://x.com/freefannie/status/1878655047715991552?s=46&t=2Y42DPZFgRdwTBHj5W8jMQ
FNMA
StockItOut StockItOut 1 hour ago
That Xeriant PR excellently written with bullshit:

""After successfully completing 75% of the demanding NFPA 286 test," meaning = "after failing the NFPA 286 test by missing 25% of the approval target testing requirement,"

"the Company used the data to make several key
XERI
gitreal gitreal 1 hour ago
You were actually partially right....BMXI has filed some SEC documents, some necessary (Form 1-A), some unnecessary (Form 4). And they do summarize a lot of the stuff that I think are fabrications....their production, mining operations, etc. Time will tell, but I think a lot of it (and probably
BMXI
RichieBoy RichieBoy 1 hour ago
Jim wrote a blurb about seeking more US business.

Help you out any? 🤨
AFFU
DesktopDR DesktopDR 1 hour ago
Any news or updates?
VPLM
Tahoe2468 Tahoe2468 1 hour ago
.0915 by Thursday....... 
KRTL
skitahoe skitahoe 1 hour ago
Remember GBM was redefined during the trial, thus some who were treated then had other forms of brain cancer. I believe the least we'll see in our label is brain cancer. Certainly GBM may be the deadliest of them, but treatment should work in all of them.

According to Google, GBM ha
NWBO
fuagf fuagf 1 hour ago
You are right about the crafty, evil, smart. Authoritarian methods have been in full view
in capturing America. While we work to do the right things they plot to capture the lot.
facts_matter14 facts_matter14 1 hour ago
If there weren’t suckers born every minute, there wouldn’t be POSRMX bag holders down as much as 99%, and there sure as hell wouldn’t be anybody believing there is a pipeline of products.






.
SRMX
StockItOut StockItOut 2 hours ago
Your "closer" keeps getting extended. Then again extended. Then again extended. -- Consider that end. Now expired, horizon end now reached, and the view clarifies and we see it to be your desperation from years ago ongoing still, to pump this at any expense, where you attempt to instill FOMO to hold
XERI
fuagf fuagf 2 hours ago
He would smother any question with words.

Your Recent History

Delayed Upgrade Clock